Please login to the form below
Israel
This page shows the latest Israel news and features for those working in and with pharma, biotech and healthcare.
Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits
The Israel-based company said the agreement is with US states, Native American tribes and local plaintiffs, with the payment spread over 13 years.
Latest news
-
UK trial of fourth vaccine dose shows increased protection against COVID-19
Countries such as Germany and Israel have already begun to offer all adults a fourth dose.
-
Longitude Prize in final stage of deciding recipients of £8m prize
50 teams are actively pursuing the Longitude Prize currently and are based in the UK, the US, Canada, Australia, Israel, Sweden, the Netherlands, Belgium, India, Turkey and Malaysia.
-
FDA grants Pfizer/BioNTech expanded EUA for an additional COVID-19 vaccine booster
The FDA’s decision is based on data from an ongoing study of 154 healthcare workers aged 18 years and older at a single centre in Israel. ... from Israel shows that an additional booster can improve protection against severe disease and death.
-
Moderna applies to FDA for authorisation for second COVID-19 booster shot for all adults
Moderna has stated that its submission is partially based on recently published data produced in the US and Israel, following the emergence of Omicron.
-
Pfizer highlights need for fourth dose of COVID-19 vaccine to FDA
Israel, Sweden and Chile have made fourth vaccination doses available to older adults and other clinically vulnerable or high-risk groups.
More from news
Approximately 3 fully matching, plus 141 partially matching documents found.
Latest Intelligence
-
The transatlantic opioid crisis
The UK has seen the fastest growth of people across the world seeking professional help for opioid addiction, surpassed only by two countries, Israel and Slovakia.
-
European pharma pips North America in remote physician engagement, according to Indegene-TEVA survey
Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1, 800 molecules to produce a wide range of generic products in nearly
-
Pharma deals continue to slide
The main manufacturing operation is in Israel with supporting operations in India and the US. ... Perrigo API (US). SK Capital (US). Asset acquisition. API manufacturing operations primarily in Israel with supporting units in US and India.
-
Taking a lean and careful approach
Clinical trials. The company is moving cautiously and set its clinical trials in Israel, Italy, Turkey and Greece.
-
Case Study: COPD Crowdshaped
and Technion - Israel Institute of Technology.
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
New hires at FibroGen, Saniona and Turbine
Prior to Sobi, Levin held commercial leadership roles of increasing strategic importance at Merck Serono across a number of countries, including the US, Sweden, Switzerland and Israel.
-
MIT chief financial officer joins Moderna Therapeutics
Israel Ruiz to serve as audit committee chair on its board of directors. ... US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee chair.
-
Proteostasis Therapeutics strengthens leadership team
Dr Gilmartin joins from AstraZeneca, where he most recently served as its senior medical lead for global medicines development, and has previously worked at Vertex Pharmaceuticals and Beth Israel Deaconess Medical
-
ClinTec appoints regional manager for Spain and Portugal
Palacios joins ClinTec from Merck, where he served as its clinical account manager and site relationship and operations lead, overseeing global trials across Spain, Portugal, Israel and the Netherlands.
-
Gregory Gallo joins Treato as chief commercial officer
Brings experience from Quest Diagnostics and Johnson &Johnson. Israel-based Treato has appointed Gregory Gallo as its new chief commercial officer.
More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
5 ways that lockdowns and restrictions could be affecting our allergies
One study,. 19. carried out in Israel, intended to investigate the impact of mask-wearing on symptom severity in nurses with chronic allergic rhinitis.
-
Travel in the time of COVID
Transmissibility is a secondary outcome, and we are unlikely to get those data until well into the summer (although some early data out of Israel and from Astra-Zeneca/Oxford look
-
Remote Patient Monitoring in the COVID-19 Era and Beyond
We also explore how Oxitone is being used to remotely supervise quarantined residents amidst the COVID-19 pandemic in Israel, the barriers to all high-risk chronic disease patients accessing “remote
-
Oradit Ido talks about the Unique Israeli Entrepreneurial Ecosystem
Orado provides an overview of why she believes Israel is unique in its approach to innovation. ... With a history of overcoming challenges, a people who pride themselves on their chutzpe (audaciousness), and a fast paced culture, she explains why she
-
Competition from within
Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘BRIC’ markets (Brazil,
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Janssen announces positive results supporting Rybrevant and lazertinib combination treatment for NSCLC
- Medscape Education Receives Joint Accreditation with Commendation to Deliver Continuing Education for Healthcare Providers
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
- NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
- Sanofi and Innovent Biologics to develop oncology drugs for patients in China
- WHO launches funding appeal for greater Horn of Africa prompted by food crisis
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Animation: Living With
- The journey from the patient's perspective...
- Achieving communication excellence by targeting the right channel at the right time
- By Danny Buckland...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
